Instil Bio (TIL) Interest Coverage Ratio (2020 - 2026)
Instil Bio (TIL) posted quarterly Interest Coverage Ratio of 4.52 for Q1 2026, up 83.77% year-over-year from 2.46 in Q1 2025, and up 25.94% quarter-over-quarter from 6.1 in Q4 2025.
Instil Bio (TIL) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Instil Bio's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 4.52 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 83.77% year-over-year to 4.52; the TTM figure through Mar 2026 stood at 8.76 (up 11.4% YoY), while the FY2025 annual figure was 13.48, down 2491.45% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 4.52, up from 6.1 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 3.82 in Q4 2023, with the low at 177.41 in Q2 2022.
- The 5-year median for Interest Coverage Ratio is 13.45 (2025), against an average of 31.97.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio tumbled 149484.07% in 2022, then jumped 85.75% in 2023.
- Instil Bio's Interest Coverage Ratio stood at 26.79 in 2022, then jumped by 85.75% to 3.82 in 2023, then retreated by 3.04% to 3.93 in 2024, then plunged by 55.01% to 6.1 in 2025, then increased by 25.94% to 4.52 in 2026.
- Business Quant data shows TIL's Interest Coverage Ratio at 4.52 in Q1 2026, 6.1 in Q4 2025, and 9.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - | -3.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.11 |
| Mar 31, 2026 | -4.52 |
| Dec 31, 2025 | -6.10 |
| Sep 30, 2025 | -9.50 |
| Jun 30, 2025 | -14.82 |
| Mar 31, 2025 | -27.83 |
| Dec 31, 2024 | -3.93 |
| Sep 30, 2024 | -11.77 |
| Jun 30, 2024 | -7.07 |
| Mar 31, 2024 | -12.09 |
| Dec 31, 2023 | -3.82 |
| Sep 30, 2023 | -33.31 |
| Jun 30, 2023 | -35.57 |
| Mar 31, 2023 | -66.80 |
| Dec 31, 2022 | -26.79 |
| Sep 30, 2022 | -70.20 |
| Jun 30, 2022 | -177.41 |
| Jun 30, 2021 | -0.12 |
| Mar 31, 2021 | -0.06 |
| Dec 31, 2020 | -0.22 |